ICC advances terpene-based research for anxiety relief
ICC is exploring terpene-derived botanical pathways through research focused on stress, mood, mental balance, and the future of evidence-based anxiety care.
A new path to anxiety relief is emerging from nature
Millions rely on benzodiazepines every day - medications that can bring short-term relief but often come with long-term consequences: dependence, tolerance, and a cycle that is difficult to break.
At ICC, we believe the future of anxiety care does not lie in stronger synthetic drugs, but in unlocking the therapeutic potential of what nature already provides.
Through rigorous research and clinical innovation, ICC is working to evaluate terpene-based approaches and the pathways they may influence across stress, mood, and mental balance.
The goal isn't just to manage anxiety - it's to restore balance, empower people, and give them back their lives.
Benzodiazepines are widely prescribed, but can lead to dependence, withdrawal, and diminished quality of life.
Terpenes found in botanicals and cannabis may offer key pathways involved in stress, mood, and mental balance.
ICC is pursuing rigorous research and clinical innovation to evaluate terpene-based approaches for anxiety relief.
This release discusses ongoing research and development. It is not medical advice and does not make a claim of regulatory approval or established clinical efficacy.
Connect with International Cannabis Company.
For media, research, formulation, or business inquiries related to this release, contact ICC directly.
Contact ICC